Items where authors include "Brooks, P."

Article

Abani, O., Abbas, A., Abbas, F. et al. (8041 more authors) (2025) Molnupiravir or nirmatrelvir–ritonavir plus usual care versus usual care alone in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial. The Lancet Infectious Diseases. ISSN 1473-3099

Abani, O., Abbas, A., Abbas, F. et al. (8021 more authors) (2025) Higher dose corticosteroids in hospitalised COVID-19 patients requiring ventilatory support (RECOVERY): a randomised, controlled, open-label, platform trial. eClinicalMedicine, 81. 103080. ISSN 2589-5370

Abani, O., Abbas, A., Abbas, F. et al. (8021 more authors) (2025) Higher dose corticosteroids in hospitalised COVID-19 patients requiring ventilatory support (RECOVERY): a randomised, controlled, open-label, platform trial. EClinicalMedicine, 81. 103080. ISSN 2589-5370

Faust, S.N., Haynes, R., Jones, C.E. et al. (7370 more authors) (2024) Immunomodulatory therapy in children with paediatric inflammatory multisystem syndrome temporally associated with SARS-CoV-2 (PIMS-TS, MIS-C; RECOVERY): a randomised, controlled, open-label, platform trial. The Lancet Child & Adolescent Health, 8 (3). pp. 190-200. ISSN 2352-4642

Faust, S.N., Haynes, R., Jones, C.E. et al. (7370 more authors) (2024) Immunomodulatory therapy in children with paediatric inflammatory multisystem syndrome temporally associated with SARS-CoV-2 (PIMS-TS, MIS-C; RECOVERY): a randomised, controlled, open-label, platform trial. The Lancet Child & Adolescent Health, 8 (3). pp. 190-200. ISSN 2352-4642

Abani, O., Abbas, A., Abbas, F. et al. (7989 more authors) (2023) Empagliflozin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial. The Lancet Diabetes & Endocrinology, 11 (12). pp. 905-914. ISSN 2213-8587

Abani, O., Abbas, A., Abbas, F. et al. (8104 more authors) (2023) Higher dose corticosteroids in patients admitted to hospital with COVID-19 who are hypoxic but not requiring ventilatory support (RECOVERY): a randomised, controlled, open-label, platform trial. The Lancet, 401 (10387). pp. 1499-1507. ISSN 0140-6736

Proceedings Paper

Currie, M., Brooks, P., Huang, Y. et al. (2 more authors) (2024) Life cycle assessment of plasma electrolytic oxidation treated aluminium alloy brake rotors. In: Proceedings of Eurobrake2024. Eurobrake2024, 17-19 Jun 2024, Mainz, Germany. Fisita .

Ghouri, I., Barker, R., Brooks, P. et al. (2 more authors) (2024) Wear Emissions From a Plasma Electrolytic Oxidation (PEO) Ceramic Coated Aluminum Alloy Brake Rotor Before and After Corrosion. In: EuroBrake 2024 Conference Proceedings. EuroBrake 2024, 17-19 Jun 2024, Mainz, Germany. Fisita .

Currie, M., Barton, D., Huang, Y. et al. (2 more authors) (2023) Comparative Life Cycle Assessment (LCA) of Lightweight Novel Environmentally Friendly Brake Rotors. In: Eurobrake Conference 2023. Eurobrake Conference 2023, 12-14 Sep 2023, Barcelona, Spain. TBC .

Ghouri, I., Barker, R., Brooks, P. et al. (1 more author) (2023) Particle Emission From An Aluminium Metal Matrix Composite (AL-MMC) Brake Rotor Before And After Corrosion. In: Proceedings of Eurobrake 2023. EuroBrake 2023, 12-14 Sep 2023, Barcelona. FISITA . (In Press)